The Current Ratio as of September 2024 (TTM) for Verrica Pharmaceuticals Inc. (VRCA) is 2.36

According to Verrica Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.36. This represents a change of -47.99% compared to the average of 4.54 of the last 4 quarters.

Verrica Pharmaceuticals Inc. (VRCA) Historical Current Ratio (quarterly & annually)

How has VRCA Current Ratio performed in the past?

The mean historical Current Ratio of Verrica Pharmaceuticals Inc. over the last ten years is 11.35. The current 2.36 Current Ratio has changed 1.98% with respect to the historical average. Over the past ten years (40 quarters), VRCA's Current Ratio was at its highest in in the September 2018 quarter at 40.26. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Verrica Pharmaceuticals Inc. (VRCA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Verrica Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Verrica Pharmaceuticals Inc. (VRCA) Average Current Ratio

How has VRCA Current Ratio performed in the past?

The current Current Ratio of Verrica Pharmaceuticals Inc. (VRCA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Verrica Pharmaceuticals Inc. (VRCA) Current Ratio vs. Peers

How is VRCA’s Current Ratio compared to its peers?

Verrica Pharmaceuticals Inc.’s Current Ratio is less than LianBio (10.06), greater than Inventiva S.A. (0.95), less than Edgewise Therapeutics, Inc. (30.24), less than Vigil Neuroscience, Inc. (8.39), less than Connect Biopharma Holdings Limited (4.99), less than Acumen Pharmaceuticals, Inc. (17.37), greater than Eton Pharmaceuticals, Inc. (1.40), less than Nuvation Bio Inc. (11.49), less than Eledon Pharmaceuticals, Inc. (14.48), less than Verona Pharma plc (8.61), less than Galera Therapeutics, Inc. (5.63), less than Arcutis Biotherapeutics, Inc. (8.46), greater than Protalix BioTherapeutics, Inc. (1.33), less than Chinook Therapeutics, Inc. (5.82), less than DICE Therapeutics, Inc. (25.88), less than Pliant Therapeutics, Inc. (14.47), less than Crinetics Pharmaceuticals, Inc. (16.09), greater than Ascendis Pharma A/S (0.74), less than Fennec Pharmaceuticals Inc. (8.02), less than Larimar Therapeutics, Inc. (10.93), less than Homology Medicines, Inc. (4.19),

Build a custom stock screener for Verrica Pharmaceuticals Inc. (VRCA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verrica Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verrica Pharmaceuticals Inc. (VRCA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verrica Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.